nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—Muscle spasticity—Riluzole—amyotrophic lateral sclerosis	0.0701	0.171	CcSEcCtD
Triazolam—CNS depression NOS—Riluzole—amyotrophic lateral sclerosis	0.0231	0.0563	CcSEcCtD
Triazolam—GABRR3—peripheral nervous system—amyotrophic lateral sclerosis	0.019	0.0576	CbGeAlD
Triazolam—GABRR2—peripheral nervous system—amyotrophic lateral sclerosis	0.0165	0.05	CbGeAlD
Triazolam—GABRR1—peripheral nervous system—amyotrophic lateral sclerosis	0.0158	0.0481	CbGeAlD
Triazolam—GABRR3—nerve—amyotrophic lateral sclerosis	0.0148	0.0449	CbGeAlD
Triazolam—GABRQ—nerve—amyotrophic lateral sclerosis	0.0148	0.0449	CbGeAlD
Triazolam—Depersonalisation—Riluzole—amyotrophic lateral sclerosis	0.0135	0.033	CcSEcCtD
Triazolam—Delusion—Riluzole—amyotrophic lateral sclerosis	0.0134	0.0327	CcSEcCtD
Triazolam—Mania—Riluzole—amyotrophic lateral sclerosis	0.0131	0.0318	CcSEcCtD
Triazolam—GABRR2—nerve—amyotrophic lateral sclerosis	0.0128	0.039	CbGeAlD
Triazolam—GABRR1—nerve—amyotrophic lateral sclerosis	0.0123	0.0375	CbGeAlD
Triazolam—TSPO—hindlimb—amyotrophic lateral sclerosis	0.0105	0.0319	CbGeAlD
Triazolam—Thinking abnormal—Riluzole—amyotrophic lateral sclerosis	0.0104	0.0252	CcSEcCtD
Triazolam—Glossitis—Riluzole—amyotrophic lateral sclerosis	0.0103	0.0251	CcSEcCtD
Triazolam—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.01	0.0244	CcSEcCtD
Triazolam—Coordination abnormal—Riluzole—amyotrophic lateral sclerosis	0.00967	0.0235	CcSEcCtD
Triazolam—Depressed level of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00916	0.0223	CcSEcCtD
Triazolam—TSPO—appendage—amyotrophic lateral sclerosis	0.00902	0.0274	CbGeAlD
Triazolam—Mental disability—Riluzole—amyotrophic lateral sclerosis	0.00824	0.0201	CcSEcCtD
Triazolam—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00815	0.0199	CcSEcCtD
Triazolam—Deafness—Riluzole—amyotrophic lateral sclerosis	0.0077	0.0188	CcSEcCtD
Triazolam—GABRA6—hindbrain—amyotrophic lateral sclerosis	0.00769	0.0234	CbGeAlD
Triazolam—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00733	0.0179	CcSEcCtD
Triazolam—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00689	0.0168	CcSEcCtD
Triazolam—Affect lability—Riluzole—amyotrophic lateral sclerosis	0.00678	0.0165	CcSEcCtD
Triazolam—Urinary retention—Riluzole—amyotrophic lateral sclerosis	0.00655	0.016	CcSEcCtD
Triazolam—Mood swings—Riluzole—amyotrophic lateral sclerosis	0.00653	0.0159	CcSEcCtD
Triazolam—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00648	0.0158	CcSEcCtD
Triazolam—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00608	0.0148	CcSEcCtD
Triazolam—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.00566	0.0172	CbGeAlD
Triazolam—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00557	0.0136	CcSEcCtD
Triazolam—Clobazam—SLC6A1—amyotrophic lateral sclerosis	0.00552	1	CrCbGaD
Triazolam—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00518	0.0126	CcSEcCtD
Triazolam—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00518	0.0126	CcSEcCtD
Triazolam—GABRA2—hindbrain—amyotrophic lateral sclerosis	0.00517	0.0157	CbGeAlD
Triazolam—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.005	0.0152	CbGeAlD
Triazolam—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00474	0.0115	CcSEcCtD
Triazolam—GABRA6—brainstem—amyotrophic lateral sclerosis	0.00441	0.0134	CbGeAlD
Triazolam—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00409	0.00996	CcSEcCtD
Triazolam—Tension—Riluzole—amyotrophic lateral sclerosis	0.00407	0.00991	CcSEcCtD
Triazolam—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00406	0.00989	CcSEcCtD
Triazolam—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00403	0.00981	CcSEcCtD
Triazolam—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00399	0.00971	CcSEcCtD
Triazolam—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00389	0.00947	CcSEcCtD
Triazolam—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00385	0.00937	CcSEcCtD
Triazolam—Agitation—Riluzole—amyotrophic lateral sclerosis	0.00381	0.00928	CcSEcCtD
Triazolam—Malaise—Riluzole—amyotrophic lateral sclerosis	0.00374	0.00911	CcSEcCtD
Triazolam—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00372	0.00906	CcSEcCtD
Triazolam—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00367	0.00893	CcSEcCtD
Triazolam—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00365	0.00888	CcSEcCtD
Triazolam—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00358	0.00872	CcSEcCtD
Triazolam—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00353	0.0086	CcSEcCtD
Triazolam—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00352	0.00857	CcSEcCtD
Triazolam—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.00349	0.0085	CcSEcCtD
Triazolam—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00345	0.00841	CcSEcCtD
Triazolam—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00341	0.00831	CcSEcCtD
Triazolam—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00339	0.00825	CcSEcCtD
Triazolam—Shock—Riluzole—amyotrophic lateral sclerosis	0.00333	0.00811	CcSEcCtD
Triazolam—GABRR3—nervous system—amyotrophic lateral sclerosis	0.00333	0.0101	CbGeAlD
Triazolam—GABRQ—nervous system—amyotrophic lateral sclerosis	0.00333	0.0101	CbGeAlD
Triazolam—Tachycardia—Riluzole—amyotrophic lateral sclerosis	0.0033	0.00805	CcSEcCtD
Triazolam—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00327	0.00797	CcSEcCtD
Triazolam—GABRB2—brainstem—amyotrophic lateral sclerosis	0.00325	0.00986	CbGeAlD
Triazolam—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00323	0.00786	CcSEcCtD
Triazolam—GABRD—medulla oblongata—amyotrophic lateral sclerosis	0.00321	0.00976	CbGeAlD
Triazolam—GABRQ—central nervous system—amyotrophic lateral sclerosis	0.0032	0.00973	CbGeAlD
Triazolam—GABRG1—medulla oblongata—amyotrophic lateral sclerosis	0.00309	0.00939	CbGeAlD
Triazolam—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00306	0.00746	CcSEcCtD
Triazolam—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00304	0.0074	CcSEcCtD
Triazolam—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00302	0.00735	CcSEcCtD
Triazolam—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00301	0.00733	CcSEcCtD
Triazolam—GABRB1—medulla oblongata—amyotrophic lateral sclerosis	0.003	0.00911	CbGeAlD
Triazolam—TSPO—embryo—amyotrophic lateral sclerosis	0.003	0.0091	CbGeAlD
Triazolam—GABRA2—brainstem—amyotrophic lateral sclerosis	0.00296	0.00901	CbGeAlD
Triazolam—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00294	0.00717	CcSEcCtD
Triazolam—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00292	0.00711	CcSEcCtD
Triazolam—GABRG3—nervous system—amyotrophic lateral sclerosis	0.00291	0.00885	CbGeAlD
Triazolam—Pain—Riluzole—amyotrophic lateral sclerosis	0.0029	0.00705	CcSEcCtD
Triazolam—Constipation—Riluzole—amyotrophic lateral sclerosis	0.0029	0.00705	CcSEcCtD
Triazolam—GABRR2—nervous system—amyotrophic lateral sclerosis	0.00288	0.00876	CbGeAlD
Triazolam—GABRA1—brainstem—amyotrophic lateral sclerosis	0.00287	0.0087	CbGeAlD
Triazolam—GABRG3—central nervous system—amyotrophic lateral sclerosis	0.00281	0.00852	CbGeAlD
Triazolam—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00279	0.0068	CcSEcCtD
Triazolam—GABRR1—nervous system—amyotrophic lateral sclerosis	0.00278	0.00844	CbGeAlD
Triazolam—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00277	0.00674	CcSEcCtD
Triazolam—GABRG1—spinal cord—amyotrophic lateral sclerosis	0.00276	0.00837	CbGeAlD
Triazolam—TSPO—brainstem—amyotrophic lateral sclerosis	0.00274	0.00834	CbGeAlD
Triazolam—GABRR2—cerebellum—amyotrophic lateral sclerosis	0.00271	0.00825	CbGeAlD
Triazolam—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00268	0.00652	CcSEcCtD
Triazolam—GABRR1—central nervous system—amyotrophic lateral sclerosis	0.00267	0.00812	CbGeAlD
Triazolam—GABRB1—spinal cord—amyotrophic lateral sclerosis	0.00267	0.00812	CbGeAlD
Triazolam—GABRQ—brain—amyotrophic lateral sclerosis	0.00254	0.00773	CbGeAlD
Triazolam—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00249	0.00608	CcSEcCtD
Triazolam—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00243	0.00592	CcSEcCtD
Triazolam—GABRD—nervous system—amyotrophic lateral sclerosis	0.00241	0.00733	CbGeAlD
Triazolam—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.0024	0.00583	CcSEcCtD
Triazolam—GABRD—central nervous system—amyotrophic lateral sclerosis	0.00232	0.00706	CbGeAlD
Triazolam—GABRG1—nervous system—amyotrophic lateral sclerosis	0.00232	0.00706	CbGeAlD
Triazolam—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00232	0.00564	CcSEcCtD
Triazolam—GABRA6—nervous system—amyotrophic lateral sclerosis	0.00231	0.00702	CbGeAlD
Triazolam—GABRD—cerebellum—amyotrophic lateral sclerosis	0.00227	0.0069	CbGeAlD
Triazolam—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.00226	0.00687	CbGeAlD
Triazolam—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.00226	0.00687	CbGeAlD
Triazolam—GABRB1—nervous system—amyotrophic lateral sclerosis	0.00225	0.00684	CbGeAlD
Triazolam—GABRA5—nervous system—amyotrophic lateral sclerosis	0.00224	0.00681	CbGeAlD
Triazolam—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00224	0.00545	CcSEcCtD
Triazolam—GABRG1—central nervous system—amyotrophic lateral sclerosis	0.00224	0.00679	CbGeAlD
Triazolam—GABRG3—brain—amyotrophic lateral sclerosis	0.00223	0.00677	CbGeAlD
Triazolam—GABRA6—central nervous system—amyotrophic lateral sclerosis	0.00222	0.00675	CbGeAlD
Triazolam—GABRG1—cerebellum—amyotrophic lateral sclerosis	0.00219	0.00664	CbGeAlD
Triazolam—GABRA6—cerebellum—amyotrophic lateral sclerosis	0.00217	0.0066	CbGeAlD
Triazolam—GABRB1—central nervous system—amyotrophic lateral sclerosis	0.00217	0.00659	CbGeAlD
Triazolam—GABRA5—central nervous system—amyotrophic lateral sclerosis	0.00216	0.00655	CbGeAlD
Triazolam—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00215	0.00524	CcSEcCtD
Triazolam—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00213	0.00519	CcSEcCtD
Triazolam—GABRR1—brain—amyotrophic lateral sclerosis	0.00212	0.00645	CbGeAlD
Triazolam—Headache—Riluzole—amyotrophic lateral sclerosis	0.00212	0.00517	CcSEcCtD
Triazolam—GABRB1—cerebellum—amyotrophic lateral sclerosis	0.00212	0.00644	CbGeAlD
Triazolam—GABRA3—nervous system—amyotrophic lateral sclerosis	0.00209	0.00634	CbGeAlD
Triazolam—GABRA4—nervous system—amyotrophic lateral sclerosis	0.00203	0.00617	CbGeAlD
Triazolam—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.00202	0.00613	CbGeAlD
Triazolam—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.00202	0.00613	CbGeAlD
Triazolam—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00201	0.0049	CcSEcCtD
Triazolam—GABRA3—central nervous system—amyotrophic lateral sclerosis	0.00201	0.0061	CbGeAlD
Triazolam—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.002	0.00607	CbGeAlD
Triazolam—GABRA4—central nervous system—amyotrophic lateral sclerosis	0.00196	0.00594	CbGeAlD
Triazolam—TSPO—medulla oblongata—amyotrophic lateral sclerosis	0.00191	0.00581	CbGeAlD
Triazolam—GABRA4—cerebellum—amyotrophic lateral sclerosis	0.00191	0.00581	CbGeAlD
Triazolam—GABRD—brain—amyotrophic lateral sclerosis	0.00184	0.0056	CbGeAlD
Triazolam—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.00178	0.00541	CbGeAlD
Triazolam—GABRG1—brain—amyotrophic lateral sclerosis	0.00178	0.00539	CbGeAlD
Triazolam—GABRA6—brain—amyotrophic lateral sclerosis	0.00177	0.00536	CbGeAlD
Triazolam—GABRB3—medulla oblongata—amyotrophic lateral sclerosis	0.00174	0.00528	CbGeAlD
Triazolam—GABRB1—brain—amyotrophic lateral sclerosis	0.00172	0.00523	CbGeAlD
Triazolam—GABRA5—brain—amyotrophic lateral sclerosis	0.00171	0.0052	CbGeAlD
Triazolam—TSPO—spinal cord—amyotrophic lateral sclerosis	0.00171	0.00518	CbGeAlD
Triazolam—GABRG2—nervous system—amyotrophic lateral sclerosis	0.0017	0.00517	CbGeAlD
Triazolam—GABRB2—nervous system—amyotrophic lateral sclerosis	0.0017	0.00517	CbGeAlD
Triazolam—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.00164	0.00497	CbGeAlD
Triazolam—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.00164	0.00497	CbGeAlD
Triazolam—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.0016	0.00486	CbGeAlD
Triazolam—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.0016	0.00486	CbGeAlD
Triazolam—GABRA3—brain—amyotrophic lateral sclerosis	0.00159	0.00484	CbGeAlD
Triazolam—GABRA4—brain—amyotrophic lateral sclerosis	0.00155	0.00472	CbGeAlD
Triazolam—GABRA2—nervous system—amyotrophic lateral sclerosis	0.00155	0.00472	CbGeAlD
Triazolam—GABRB3—spinal cord—amyotrophic lateral sclerosis	0.00155	0.00471	CbGeAlD
Triazolam—GABRE—nervous system—amyotrophic lateral sclerosis	0.00154	0.00468	CbGeAlD
Triazolam—GABRA1—nervous system—amyotrophic lateral sclerosis	0.0015	0.00456	CbGeAlD
Triazolam—GABRA2—central nervous system—amyotrophic lateral sclerosis	0.0015	0.00454	CbGeAlD
Triazolam—GABRE—central nervous system—amyotrophic lateral sclerosis	0.00148	0.00451	CbGeAlD
Triazolam—GABRA2—cerebellum—amyotrophic lateral sclerosis	0.00146	0.00444	CbGeAlD
Triazolam—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.00145	0.00439	CbGeAlD
Triazolam—TSPO—nervous system—amyotrophic lateral sclerosis	0.00144	0.00437	CbGeAlD
Triazolam—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.00141	0.00429	CbGeAlD
Triazolam—TSPO—central nervous system—amyotrophic lateral sclerosis	0.00138	0.00421	CbGeAlD
Triazolam—TSPO—cerebellum—amyotrophic lateral sclerosis	0.00135	0.00411	CbGeAlD
Triazolam—GABRB3—nervous system—amyotrophic lateral sclerosis	0.00131	0.00397	CbGeAlD
Triazolam—GABRG2—brain—amyotrophic lateral sclerosis	0.0013	0.00395	CbGeAlD
Triazolam—GABRB2—brain—amyotrophic lateral sclerosis	0.0013	0.00395	CbGeAlD
Triazolam—GABRB3—central nervous system—amyotrophic lateral sclerosis	0.00126	0.00382	CbGeAlD
Triazolam—GABRB3—cerebellum—amyotrophic lateral sclerosis	0.00123	0.00373	CbGeAlD
Triazolam—GABRA2—brain—amyotrophic lateral sclerosis	0.00119	0.00361	CbGeAlD
Triazolam—GABRE—brain—amyotrophic lateral sclerosis	0.00118	0.00358	CbGeAlD
Triazolam—GABRA1—brain—amyotrophic lateral sclerosis	0.00115	0.00349	CbGeAlD
Triazolam—TSPO—brain—amyotrophic lateral sclerosis	0.0011	0.00334	CbGeAlD
Triazolam—GABRB3—brain—amyotrophic lateral sclerosis	0.000998	0.00303	CbGeAlD
Triazolam—CYP2C8—brain—amyotrophic lateral sclerosis	0.000754	0.00229	CbGeAlD
Triazolam—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000668	0.00203	CbGeAlD
Triazolam—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000644	0.00195	CbGeAlD
Triazolam—GABRB3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000523	0.00205	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000522	0.00205	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.00052	0.00204	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.00052	0.00204	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000518	0.00203	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000517	0.00203	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000517	0.00203	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000513	0.00201	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000508	0.00199	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000508	0.00199	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000506	0.00199	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000505	0.00198	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000505	0.00198	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000503	0.00198	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.0005	0.00196	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.0005	0.00196	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000498	0.00195	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000498	0.00195	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000496	0.00195	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000495	0.00194	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000494	0.00194	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000488	0.00192	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000486	0.00191	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000485	0.00191	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000482	0.00189	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.00048	0.00189	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000477	0.00187	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000477	0.00187	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000474	0.00186	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000472	0.00185	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000471	0.00185	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000471	0.00185	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000469	0.00184	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000466	0.00183	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000465	0.00183	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000465	0.00183	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000464	0.00182	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000462	0.00181	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—SQSTM1—amyotrophic lateral sclerosis	0.000462	0.00181	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000461	0.00181	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000457	0.0018	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000457	0.0018	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000456	0.00179	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000452	0.00178	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00045	0.00177	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000448	0.00176	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000444	0.00174	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000444	0.00174	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000444	0.00174	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000443	0.00174	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000436	0.00171	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000429	0.00168	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000426	0.00167	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000425	0.00167	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000425	0.00167	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00042	0.00165	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000418	0.00164	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000417	0.00164	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000414	0.00163	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000414	0.00163	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000413	0.00162	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000413	0.00162	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000407	0.0016	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000406	0.00159	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000406	0.00159	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000405	0.00159	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.0004	0.00157	CbGpPWpGaD
Triazolam—CYP3A5—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.0004	0.00157	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000399	0.00157	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000399	0.00157	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000398	0.00156	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000396	0.00156	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000396	0.00156	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000395	0.00155	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000391	0.00154	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000389	0.00153	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000389	0.00153	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000389	0.00153	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000388	0.00152	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000388	0.00152	CbGpPWpGaD
Triazolam—CYP2C8—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000382	0.0015	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000382	0.0015	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000379	0.00149	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000368	0.00145	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000366	0.00144	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000362	0.00142	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000355	0.0014	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000353	0.00139	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—BDNF—amyotrophic lateral sclerosis	0.000348	0.00137	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000347	0.00136	CbGpPWpGaD
Triazolam—CYP2C8—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000346	0.00136	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000346	0.00136	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000346	0.00136	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.00034	0.00133	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.00034	0.00133	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000334	0.00131	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00033	0.0013	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00033	0.0013	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00033	0.0013	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00033	0.0013	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000319	0.00125	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000315	0.00124	CbGpPWpGaD
Triazolam—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000311	0.00122	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000308	0.00121	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000303	0.00119	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000298	0.00117	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000294	0.00115	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000294	0.00115	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000294	0.00115	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000282	0.00111	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00028	0.0011	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000272	0.00107	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000272	0.00107	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000269	0.00106	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000268	0.00105	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000268	0.00105	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000266	0.00105	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000261	0.00103	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000256	0.00101	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000253	0.000994	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000253	0.000994	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000252	0.00099	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.00025	0.000983	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.00025	0.000981	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.00025	0.000981	CbGpPWpGaD
Triazolam—CYP3A7—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000247	0.000971	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000246	0.000966	CbGpPWpGaD
Triazolam—CYP3A7—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000244	0.000958	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000244	0.000957	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000242	0.000951	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000238	0.000936	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000229	0.000898	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000229	0.000898	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000227	0.00089	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000226	0.000886	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000223	0.000875	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000222	0.000872	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000222	0.000872	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000218	0.000856	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000218	0.000856	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000217	0.000852	CbGpPWpGaD
Triazolam—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000216	0.000847	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000215	0.000844	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000214	0.000842	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000214	0.000842	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000213	0.000837	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000213	0.000836	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000213	0.000836	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000209	0.000821	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000209	0.000821	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000204	0.0008	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000198	0.000779	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000198	0.000777	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000194	0.000763	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000191	0.00075	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00019	0.000745	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00019	0.000744	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00019	0.000744	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000186	0.000732	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000186	0.000729	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000184	0.000724	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000183	0.000718	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000183	0.000718	CbGpPWpGaD
Triazolam—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000179	0.000702	CbGpPWpGaD
Triazolam—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000176	0.000692	CbGpPWpGaD
Triazolam—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000175	0.000689	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000174	0.000682	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000173	0.000681	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000173	0.000681	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000163	0.00064	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000161	0.000633	CbGpPWpGaD
Triazolam—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000155	0.000608	CbGpPWpGaD
Triazolam—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000153	0.0006	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000152	0.000595	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000146	0.000573	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.00014	0.000549	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	0.000137	0.000538	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000137	0.000538	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000137	0.000538	CbGpPWpGaD
Triazolam—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000126	0.000495	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000125	0.000492	CbGpPWpGaD
Triazolam—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000124	0.000488	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000119	0.000467	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000119	0.000466	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000119	0.000466	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000119	0.000466	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000116	0.000457	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000111	0.000435	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00011	0.00043	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000109	0.000426	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000104	0.000408	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000101	0.000396	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	9.91e-05	0.000389	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	9.66e-05	0.000379	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	9.66e-05	0.000379	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	9.58e-05	0.000376	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	9.49e-05	0.000373	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	9.01e-05	0.000354	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	8.83e-05	0.000347	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	8.58e-05	0.000337	CbGpPWpGaD
Triazolam—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	8.31e-05	0.000326	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	8.21e-05	0.000322	CbGpPWpGaD
Triazolam—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	8.2e-05	0.000322	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	7.87e-05	0.000309	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	7.72e-05	0.000303	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	7.51e-05	0.000295	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	6.98e-05	0.000274	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	6.93e-05	0.000272	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	6.5e-05	0.000255	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	6.37e-05	0.00025	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	6.37e-05	0.00025	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	6e-05	0.000236	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	5.83e-05	0.000229	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	5.69e-05	0.000223	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.46e-05	0.000215	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.42e-05	0.000213	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	5.29e-05	0.000208	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	5.09e-05	0.0002	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	4.93e-05	0.000194	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	4.88e-05	0.000192	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	4.61e-05	0.000181	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.5e-05	0.000177	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.45e-05	0.000175	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.23e-05	0.000166	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	4.01e-05	0.000157	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.89e-05	0.000153	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.66e-05	0.000144	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	3.49e-05	0.000137	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	3.22e-05	0.000126	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	3.2e-05	0.000126	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.08e-05	0.000121	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.06e-05	0.00012	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.81e-05	0.00011	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.65e-05	0.000104	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.65e-05	0.000104	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.51e-05	9.85e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.43e-05	9.56e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	2.31e-05	9.08e-05	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.19e-05	8.61e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.16e-05	8.46e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	2e-05	7.86e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.98e-05	7.78e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.63e-05	6.4e-05	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.58e-05	6.22e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.42e-05	5.58e-05	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.37e-05	5.39e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.31e-05	5.13e-05	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.12e-05	4.39e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.07e-05	4.22e-05	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.36e-06	2.89e-05	CbGpPWpGaD
